Search Results

You are looking at 1 - 10 of 13 items for :

  • "new-onset diabetes" x
Clear All
Open access

Early arteriosclerosis and its risk factors in subjects with prediabetes and new-onset diabetes

Xiaoli Liu, Lanxiang Liu, Rui Wang, Xiaojiao Jia, Binbin Liu, Ning Ma, and Qiang Lu

prediabetes and new-onset diabetes. As a basic characteristic of type 2 diabetes mellitus (T2DM), insulin resistance plays an important role in the development and progression of arteriosclerosis. Insulin resistance is present in prediabetes, and populations

Open access

Pancreatic and gut hormones as predictors of new-onset prediabetes after non-necrotising acute pancreatitis: a prospective longitudinal cohort study

Sakina H Bharmal, Wandia Kimita, Juyeon Ko, and Maxim S Petrov

from several studies suggests that individuals with AP are at a two-times increased risk of new-onset diabetes than the general population, independent of the severity of AP ( 5 , 6 , 7 ). Given that the cumulative incidence of new-onset diabetes

Open access

Simvastatin profoundly impairs energy metabolism in primary human muscle cells

Selina Mäkinen, Neeta Datta, Yen H Nguyen, Petro Kyrylenko, Markku Laakso, and Heikki A Koistinen

in patients with type 2 diabetes ( 8 ). Regarding individual statins, simvastatin or rosuvastatin use was associated with the highest risk for type 2 diabetes, whereas pravastatin use was associated with low risk of new-onset diabetes ( 9 ). Statins

Open access

Effect of plasma glucose at admission on COVID-19 mortality: experience from a tertiary hospital

Bharat Kumar, Madhukar Mittal, Maya Gopalakrishnan, Mahendra K Garg, and Sanjeev Misra

Rani CS Jeba Rani S Gupta R Jha A Gupta V Kuchay MS Luthra A Durrani S et al . Glycemic parameters in patients with new-onset diabetes during COVID-19 pandemic are more severe than in patients with new-onset diabetes before the pandemic

Open access

The effect of atorvastatin on pancreatic beta cell requirement in women with polycystic ovary syndrome

Thozhukat Sathyapalan, Anne-Marie Coady, Eric S Kilpatrick, and Stephen L Atkin

-analysis . Diabetes Care 2009 32 1924 – 1929 . ( doi:10.2337/dbib9-0738 ) 19794004 10.2337/dc09-0738 5 Waters DD Ho JE DeMicco DA Breazna A Arsenault BJ Wun CC Kastelein JJ Colhoun H Barter P. Predictors of new-onset

Open access

Insulin-like growth factor role in determining the anti-cancer effect of metformin: RCT in prostate cancer patients

Vita Birzniece, Teresa Lam, Mark McLean, Navneeta Reddy, Haleh Shahidipour, Amy Hayden, Howard Gurney, Glenn Stone, Rikke Hjortebjerg, and Jan Frystyk

controls ( 3 ). Insulin resistance is increased by more than 30% as early as 3 months after the initiation of ADT ( 4 ), and the risk of new-onset diabetes is increased four- to five-fold in the first year of treatment ( 5 ). These conditions are known to

Open access

Autoimmune thyroid disease correlates to islet autoimmunity on zinc transporter 8 autoantibody

Yun Cai, Jieni Yan, Yong Gu, Heng Chen, Yang Chen, Xinyu Xu, Mei Zhang, Liping Yu, Xuqin Zheng, and Tao Yang

non-obese adults with new-onset diabetes? European Journal of Endocrinology 2014 170 651 – 658 . ( ) 26 Gu Y Zhang M Chen H Wang Z Xing C Yang H Xu X Liu Y Zhou Z Yu L Discordant

Open access

Endocrine toxicity of cancer immunotherapy: clinical challenges

Bliss Anderson and Daniel L Morganstein

) Usually 1–3 months after treatment Hyperglycaemia and new-onset diabetes Approximately 1% (59) Anti-PD-1/PD-L1 (58, 61, 62) Polydipsia, polyuria, weight loss Hyperglycaemia on fasting and random glucose samples, HbA1c Persistent

Open access

Novel therapies for acromegaly

Bernardo Maia, Leandro Kasuki, and Mônica R Gadelha

Pasireotide + Pegvisomant (38) Somatostatin receptor ligand + GHR antagonist Phase 4 Pasireotide 60 mg IM monthly + Pegvisomant 21-78 mg SC weekly 73.8 NA Hyperglycemia, new-onset diabetes, gastrointestinal, myalgia, fatigue, headache, arthralgia

Open access

Early and late endocrine complications of COVID-19

Paraskevi Kazakou, Stavroula A Paschou, Theodora Psaltopoulou, Maria Gavriatopoulou, Eleni Korompoki, Katerina Stefanaki, Fotini Kanouta, Georgia N Kassi, Meletios-Athanasios Dimopoulos, and Asimina Mitrakou

. Emerging Infectious Diseases 2020 26 1618 – 1620 . ( ) 38 Rubino F Amiel SA Zimmet P Alberti G Bornstein S Eckel RH Mingrone G Boehm B Cooper ME Chai Z New-onset diabetes in Covid-19 . New